Aviron Message Board - Msg: 16140210

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Aviron

AVIR 3.250

-0.6%

Oct 31 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: A.J. Mullen who wrote (620)	7/28/2001 3:34:15 PM
From: tuck	Read Replies (1) of 645

S.G. Cowen's Eric Schmidt (sp?) holds out some possibility that the FDA and AVIR could get together in a few months and reverse this decision, impying no need for further trials. Six of the ten no votes being provisional pending the requested safety data. Few informed folks have said another trial is needed, but the folks I've seen that said or implied this (including Mr. Schmidt/Cowen) have an interest in AVIR doing well. The 2.5 minute audio take featuring Mr. Schmidt is accessible here: biz.yahoo.com This does amplify the idea that AVIR and FDA were on different pages regarding how much safety data was needed. What we have here is a failure to communicate. FDA timidity or Aviron's regulatory inexperience? Can't say. Cheers, Tuck

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next